Search

everythinglearnresearchcommunity

for

Search:↓

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Sex hormone supplements help improve breathing and nerve recovery after spinal injury in rats.

DHEA therapy improves pubic hair growth and psychological well-being in young females with central adrenal insufficiency.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Gene therapy helped rats with a specific type of rickets grow hair without severe inflammation.

Testosterone therapy improved physical and social health in a male with 49,XXXXY syndrome.

Dutasteride is more effective than finasteride for hair loss, but more research is needed on safety and dosing.

Topical immunotherapy is more effective than dapsone for treating severe alopecia areata.

Trichotillomania was successfully treated with risperidone and naltrexone.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

Diphenylcyclopropenone (DPCP) is effective in treating alopecia areata, with most patients showing significant hair regrowth.

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

DPCP alone is more effective and safer for treating chronic extensive alopecia areata than combining it with anthralin.

N-acetylcysteine and memantine are recommended as safe and effective treatments for trichotillomania.

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.

DHEA therapy improves pubic hair growth and psychological well-being in girls with central adrenal insufficiency.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Injecting 6-OHDA in newborn mice delays hair growth and thins skin.

Finasteride improved reflexes and motor activity in rats with liver-related brain issues.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Light therapy can effectively treat vitiligo and hair loss caused by a specific medication.

High-dose steroid pulse therapy effectively regrows hair in severe multifocal alopecia areata.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

The data suggests that dosing differences can help manage spasticity in patients with upper motor neuron dysfunction.

Low-dose radiation therapy may improve brain function in some Alzheimer's patients and is generally well-tolerated.